Hospital profits on the decline

Hospitals are seeing a drop in profitability, according to a flash report from Kaufman Hall.

In August, hospital profitability dropped for the second month in 2019, with EBITDA margins dropping 9.4%, according to the report. Compared to the same time last year, operating margin declined 11.4%.

The declines, which affected all geographic groins and bed sizes, were driven by softening volumes, according to the report, with inpatient discharges, emergency department visits and operating room volumes all dropping more than 1.5% from last year. Hospitals are having a hard time adjusting expenses when volumes drop in order to keep profitability at the same level, with volume and profitability being inextricably linked, the report noted.

Volume performance for August was mixed after higher volumes in July, with discharges dropping 1.5% year over year. Overall length of stay did rise 2.1% from August 2018, but both emergency department visits and operating room minutes dropped 2.8% and 2.6%, respectively, compared to budget.

Also during the month, bad debt and charity care rose 5% from August 2018.

“Hospitals nationwide continue to struggle with rising levels of unpaid care,” the report reads.

Overall during the month, revenue per unit was lower than July, though net patient service revenue (NPSR) per adjusted discharge was up 3.6% year over year.

With these struggles, hospitals also saw a mixed month of expenses, according to the report. Non-labor expenses in particular are driving year-over-year rise sin expenses. Non-labor expenses per adjusted discharge rose 3.5% in August from a year prior. Labor expense rose 2.4% year over year.

The hospital report came as the U.S. economy was seeing new fears about a future recession, with the manufacturing sector contracting below 50% and a yield-curve inversion in U.S. treasuries.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.